Susquehanna International Group
BNGO icon

Susquehanna International Group’s Bionano Genomics BNGO Stock Holding History

Susquehanna International Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-563
Closed -$63.9K – 12198
2023
Q4 		$63.9K Sell
563
-1,082
-66% -$113K ﹤0.01% 11605
2023
Q3 		$299K Buy
1,645
+1,468
+829% +$385K ﹤0.01% 9357
2023
Q2 		$64.7K Sell
177
-244
-58% -$110K ﹤0.01% 11220
2023
Q1 		$280K Buy
421
+49
+13% +$43.5K ﹤0.01% 9867
2022
Q4 		$325K Sell
372
-355
-49% -$447K ﹤0.01% 8894
2022
Q3 		$798K Sell
727
-49
-6% -$64.7K ﹤0.01% 7231
2022
Q2 		$643K Sell
776
-354
-31% -$364K ﹤0.01% 7647
2022
Q1 		$1.75M Sell
1,130
-407
-26% -$549K ﹤0.01% 5782
2021
Q4 		$2.76M Sell
1,537
-38
-2% -$102K ﹤0.01% 4802
2021
Q3 		$5.2M Sell
1,575
-1,582
-50% -$5.53M ﹤0.01% 3879
2021
Q2 		$13.9M Buy
3,157
+364
+13% +$1.44M ﹤0.01% 2466
2021
Q1 		$13.5M Buy
+2,793
New +$15.7M ﹤0.01% 2353

Other funds holding BNGO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's BNGO Position: Q1 2025 in Review

Susquehanna International Group sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 3,553 shares — an estimated $23.3K sold.

Susquehanna International Group first reported a position in BNGO in Q4 2020 and held it in 17 quarters. The position peaked at $20.6M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Susquehanna International Group reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 3,553 Bionano Genomics shares in Q1 2025, an estimated $23.3K.
  • Susquehanna International Group first reported a position in Bionano Genomics in Q4 2020 and held it in 17 quarters.
  • Susquehanna International Group's Bionano Genomics position peaked at $20.6M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.